Shares of Bruker Corp. (BRKR) plummeted as much as 5.86% in pre-market trading on Monday, following the release of the company's third-quarter 2024 financial results.
The scientific instruments and analytical solutions provider reported adjusted earnings per share of $0.60 for the quarter, narrowly beating analysts' expectations of $0.59. However, revenue of $864.4 million, while surpassing the consensus estimate of $859.4 million, fell short of investors' expectations.
More concerning, Bruker's full-year 2024 revenue guidance range of $3.34 billion to $3.37 billion fell below the analyst consensus of $3.40 billion, indicating potential headwinds or weak demand in the company's core markets.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。